LPA leaps

Credit: Journal of Biological Chemistry, vol. 280, issue 41, 10/14/05, courtesy of Yuko Fujiwara, University of Tennessee Cancer Institute, Memphis, TN" /> Credit: Journal of Biological Chemistry, vol. 280, issue 41, 10/14/05, courtesy of Yuko Fujiwara, University of Tennessee Cancer Institute, Memphis, TN The paper: J. Chun et al., "GPR92 as a new G(12/13)- and G(q)-coupled lysophosphatidic acid receptor tha

Written byJennifer Evans
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

J. Chun et al., "GPR92 as a new G(12/13)- and G(q)-coupled lysophosphatidic acid receptor that increases cAMP, LPA(5)," J Biol Chem, 281:23589-97, 2006. (Cited in 75 papers)

Between 1996 and 2006, researchers identified four G protein-coupled receptors (GPCRs) as lysophosphatidic acid (LPA) receptors, LPA1-4. Jerold Chun's team at The Scripps Research Institute screened collections of orphan GPCRs, using reverse transfection to measure LPA-dependent cellular morphological changes, and identified a potential LPA receptor. Through heterologous expression and measuring downstream signaling, Chun identified GPR92 as a new receptor, LPA5.

Sequencing revealed that LPA5 shared homology with LPA4, but not the other three, suggesting there were at least two distinct families of LPA receptors. "People are now looking more seriously at the possibility of other non-homologous [LPA] receptors, mediating a variety of physiological and pathophysiological actions," says Chun, suggesting the two subfamilies mediate different cellular responses.

Since publication, researchers have reconfirmed LPA4-5 to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies